Skip to main content
SpringerLink
Log in

Adalimumab/apremilast

Rebound psoriasis flare-up and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Saura SP, et al. Successful outcome of psoriasis in a laryngeal cancer patient treated with ixekizumab, a possible beneficial treatment for both pathologies. Dermatology Online Journal 27: No. 6, 2021. Available from: URL: https://escholarship.org/uc/item/9v7926vr

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/apremilast. Reactions Weekly 1892, 15 (2022). https://doi.org/10.1007/s40278-022-09557-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-09557-1

Search

Navigation